Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
Aim.То study the levels of asymmetric dimethylarginine (ADMA) and NO metabolites in patients with ST elevation acute coronary syndrome (ACS-ST), as well as in patients with stable effort angina (SEA). Material and methods. The study involved 35 patients: 20 with ACS-ST (mean age 57,4±9,2 years) and...
Main Authors: | A. S. Galyavich, E. R. Gaynutdinov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-02-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1137 |
Similar Items
-
RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
by: S. R. Willoughby, et al.
Published: (2015-12-01) -
OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!
by: M. Marzilli, et al.
Published: (2015-12-01) -
THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE
by: M. V. Ilyin, et al.
Published: (2015-12-01) -
The role of melatonin in pathogenesis of cardiovascular diseases
by: A. V. Budnevsky, et al.
Published: (2016-10-01) -
Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)